Use of methylene blue for the detection of sentinel lymph node in breast cancer: a systematic review and meta-analysis

Madhivadhanam Parasuraman; Bhanumati Giridharan; . Vijaylakshmi

doi:10.18203/2349-2902.isj20175879

Authors

Madhivadhanam Parasuraman Department of General Surgery, ESIC Medical College and PGIMSR, Chennai, Tamil Nadu, India
Bhanumati Giridharan Department of General Surgery, ESIC Medical College and PGIMSR, Chennai, Tamil Nadu, India
. Vijaylakshmi Department of General Surgery, ESIC Medical College and PGIMSR, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2349-2902.isj20175879

Keywords:

Breast cancer, Methylene blue dye, Sentinel lymph node biopsy

Abstract

Sentinel lymph node biopsy is the widely acceptable method for the examination of the breast cancer in the patients. This biopsy is considered as the best method for identifying the axillary involvement. Various dyes are used in this biopsy to find the sentinel lymph node. However, methylene blue dye (MBD) is considered to have a low risk of anaphylaxis, be cost effective and widely available.

A systematic review and meta-analysis is performed on the utilisation of the methylene blue dye in the sentinel lymph node biopsy in the examination of breast cancer.

Eight studies were appropriate for the inclusion criteria that were analysed systematically wherein meta- analysis is performed on studies which had ample data that comparatively analysed the efficiency of methylene blue. However, only two studies were selected for meta- analysis based on the availability of data.

Systematic review reveals that methylene blue dye can be used as the best alternative when compared to other dyes in the detection of sentinel lymph node in the patients with breast cancer. However, the meta-analysis of two studies revealed no statistical significance defining the efficacy of methylene blue for sentinel lymph node detection.

Metrics

Metrics Loading ...

References

Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Sur. 1992;127(4):392-9.

Albo D, Wayne JD, Hunt KK, Rahlfs TF, Singletary SE, Ames FC, et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg. 2001;182(4):393-8.

Laurie SA, Khan DA, Gruchalla RS, Peters G. Anaphylaxis to isosulfan blue. Ann Allergy, Asthma Immunol. 2002;88(1):64-6.

Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial. JNCI J Natl Cancer Inst. 2006;98(9):599-609.

Chua B, Ung O, Boyages J. Treatment of the axilla in early breast cancer: past, present and future. ANZ J Surg. 2001;71(12):729-36.

Veronesi U, Marubini E, Vecchio MD, Manzari A, Andreola S, Greco M, et al. Local Recurrences and Distant Metastases After Conservative Breast Cancer Treatments: Partly Independent Events. JNCI J Natl Cancer Inst. 1995;87(1):19-27.

Veronesi U, Viale G, Paganelli G, Zurrida S, Luini A, Galimberti V, et al. Sentinel Lymph Node Biopsy in Breast Cancer: ten-year results of a randomized controlled study. Ann Surg. 2010;251(4):595-600.

Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997;15(6):2345-50.

East JM, Valentine CS, Kanchev E, Blake GO. Sentinel lymph node biopsy for breast cancer using methylene blue dye manifests a short learning curve among experienced surgeons: a prospective tabular cumulative sum (CUSUM) analysis. BMC Surg. 2009;9(1):2.

Varghese P, Abdel-Rahman AT, Akberali S, Mostafa A, Gattuso JM, Carpenter R. Methylene Blue Dye-A Safe and Effective Alternative for Sentinel Lymph Node Localization. Breast J. 2008;14(1):61-7.

Eldrageely K, Vargas MP, Khalkhali I, Venegas R, Burla M, Gonzalez KD, et al. Sentinel lymph node mapping of breast cancer: a case-control study of methylene blue tracer compared to isosulfan blue. Am Surg. 2004;70(10):872-5.

Blessing WD, Stolier AJ, Teng SC, Bolton JS, Fuhrman GM. A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping. Am J Surg. 2002;184(4):341-5.

Masannat Y, Shenoy H, Speirs V, Hanby A, Horgan K. Properties and characteristics of the dyes injected to assist axillary sentinel node localization in breast surgery. Eur J Surg Oncol. 2006;32(4):381-4.

Aydogan F, Celik V, Uras C, Salihoglu Z, Topuz U. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg. 2008;195(2):277-8.

Thevarajah S, Huston TL, Simmons RM. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg. 2005;189(2):236-9.

Golshan M, Nakhlis F. Can Methylene Blue Only Be Used in Sentinel Lymph Node Biopsy for Breast Cancer? Breast J. 2006;12(5):428-30.

Stradling B, Aranha G, Gabram S. Adverse skin lesions after methylene blue injections for sentinel lymph node localization. Am J Surg. 2002;184(4):350-2.

Cox CE, Salud CJ, Harrinton MA. The role of selective sentinel lymph node dissection in breast cancer. Surg Clin North Am. 2000;80(6):1759–77.

Mathelin C, Croce S, Brasse D, Gairard B, Gharbi M, Andriamisandratsoa N, et al. Methylene Blue Dye, an Accurate Dye for Sentinel Lymph Node Identification in Early Breast Cancer. Anticancer Res. 2009;29:4119-26.

Zaazou M, Khaled M, Merhem I, Azeem AA. Sentinel Lymph Node Biopsy Using Methylene Blue Dye in Early Breast Cancer. Is It Truly Reliable. Researchgate. 2017.

Nour A. Efficacy of Methylene Blue Dye in Localization of Sentinel Lymph Node in Breast Cancer Patients. Breast J. 2004;10(5):388-91.

Simmons R, Thevarajah S, Brennan MB, Christos P, Osborne M. Methylene Blue Dye as an Alternative to Isosulfan Blue Dye for Sentinel Lymph Node Localization. Ann Surg Oncol. 2003;10(3):242-7.

Yong WS, Wong CY, Lee JSY, Soo KC, Tan PH, Goh ASW. Single institution’s initial experience with sentinel lymph node biopsy in breast cancer patients. ANZ J Surg. 2003;73(6):416-21.

Ross MI. Sentinel node dissection in early-stage breast cancer: ongoing prospective randomized trials in the USA. Ann Surg Oncol. 2001;8:77S-81.

Fenaroli P, Merson M, Giuliano L, Bonasegale A, Virotta G, Pericotti S, et al. Population-based sentinel lymph node biopsy in early invasive breast cancer. Eur J Surg Oncol. 2004;30(6):618-23.

Sohail A, Sohail M, Asim M, Shakir J, Durrani KM. Evaluation of Sentinel Lymph Node Biopsy with Methylene Blue Dye in Early Carcinoma Breast. Pakistan J Med Heal Sci. 2010;4(3):233-6.

Manbel R, Cunnick G. Analysis of potential risk for failed localization of axillary sentinel node in breast cancer. Breast cancer Res Treat Spec issue 24th Annu Sanantonia Breast Cancer Symp. 2001;24:341-4.

Eary JF, Mankoff DA, Dunnwald LK, Byrd DR, Anderson BO, Yeung RS, et al. Sentinel Lymph Node Mapping for Breast Cancer: Analysis in a Diverse Patient Group. Radiology. 1999;213(2):526-9.

O’Hea BJ, Hill AD, El-Shirbiny AM, Yeh SD, Rosen PP, Coit DG, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg. 1998;186(4):423-7.

Ozdemir A, Mayir B, Demirbakan K, Oygur N. Efficacy of Methylene Blue in Sentinel Lymph Node Biopsy for Early Breast Cancer. J Breast Heal. 2014;10(2):88-91.

Altıntoprak F, Igci A, Asoglu O, Gok K, Muslumanoglu M, Ozmen V, et al. Allergic reaction due to subareolar isosulphane blue dye injection for sentinel lymph node biopsy: Case Report. J Breast Heal. 2006;2:34-6.

Fattahi AS, Tavassoli A, Rohbakhshfar O, Sadeghi R, Abdollahi A, Forghan MN. Can methylene blue dye be used as an alternative to patent blue dye to find the sentinel lymph node in breast cancer surgery. J Res Med Sci. 2014;918-22.

Kasula J, Ramakrishna PC, Rao UM, Masood SV. Role of Sentinel Lymphnode Biopsy in Carcinoma Breast Using Methylene Blue Dye. IOSR J Dent Med Sci. 2016;15(4):1-4.

Varghese P, Mostafa A, Abdel-Rahman AT, Akberali S, Gattuso J, Canizales A, et al. Methylene blue dye versus combined dye-radioactive tracer technique for sentinel lymph node localisation in early breast cancer. Eur J Surg Oncol. 2007;33(2):147-52.

Paulinelli RR, Freitas-Junior R, Rahal RM de S, Oliveira LF de P, Vilela MHT, Moreira MAR, et al. A prospective randomized trial comparing patent blue and methylene blue for the detection of the sentinel lymph node in breast cancer patients. Rev Assoc Med Bras. 2017;63(2):118-23.